NIH-funded research R01 grant

Twice-reading RNA sequencing to better map RNA modifications

Official title: Twice reading of RNA by direct nanopore sequencing

Funded at Thomas Jefferson University · NIH-11599436 · Data updated 2026-11-12

Researchers are using a novel method to read RNA twice to more accurately map chemical modifications in human transcripts, which could help us understand health and disease.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionThomas Jefferson University
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startMay 1, 2024
Project endFebruary 29, 2028
Funding year2026
Award (this year)$112,568
NIH project number3R01HG013302-03S1
Project IDNIH-11599436 on NIH RePORTER

Who could benefit from this research

Could help

Not applicable to a specific patient population at this stage; potential future relevance includes researchers and clinicians studying RNA biology in human health and disease.

Less likely to help

Direct clinical benefit to patients may not occur in the near term; the grant focuses on methodological advances in RNA sequencing.

What this research studies

This project aims to improve how we detect and quantify RNA modifications by using the 3Dpol enzyme to create a double-read of each RNA molecule during nanopore sequencing. The approach links the original RNA strand with a copied strand, giving a higher-fidelity reference to compare against the nanopore read. By analyzing how these modifications influence sequencing accuracy, the project hopes to establish clearer modification maps that relate to gene expression and cell fate. The work combines molecular biology with nanotechnology to push forward our ability to study human transcriptomes at a finer level.

Why it matters

Potential benefit: If successful, this method could lead to more accurate maps of RNA modifications, enhancing our understanding of gene regulation and potentially informing research into human diseases.

How similar studies have gone: Previous work shows nanopore sequencing can detect RNA modifications, but accuracy and quantification remain challenging, making this approach innovative.

Where this research is happening

  • Thomas Jefferson University
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Hou, Ya-Ming — Thomas Jefferson University
  • Study coordinator: Hou, Ya-Ming

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.